PMEL and melanoma: In healthy individuals (and not in melanoma patients), melanoma-specific T lymphocytes displaying a strong reactivity against peptides of melanoma antigens Tyrosinase–MAGEA3–Melan-A/Mart-1–Pmel 17gp100 and NY-ESO-1 have been identified [200].